{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "340",
                "350"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Salbutamol"
        },
        {
            "identifier": "T2",
            "position": [
                "576",
                "584"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji"
        },
        {
            "identifier": "T3",
            "position": [
                "612",
                "636"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "choroby w\u0119z\u0142a zatokowego"
        },
        {
            "identifier": "T4",
            "position": [
                "775",
                "799"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "chorob\u0105 w\u0119z\u0142a zatokowego"
        },
        {
            "identifier": "T5",
            "position": [
                "876",
                "891"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan do\u015b\u0107 dobry"
        },
        {
            "identifier": "T6",
            "position": [
                "585",
                "588"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "VSD"
        },
        {
            "identifier": "T7",
            "position": [
                "590",
                "600"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "Obserwacja"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N1",
            "referenced": "T2",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:I49.5",
            "identifier": "N2",
            "referenced": "T3",
            "subtype": "Reference",
            "type": "N",
            "value": "Zesp\u00c3\u00b3\u00c5\u0082 chorej zatoki"
        },
        {
            "icd": "ICD10:Q21.0",
            "identifier": "N3",
            "referenced": "T6",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzykomorowej"
        },
        {
            "identifier": "A1",
            "referenced": "T3",
            "subtype": "Source",
            "type": "A",
            "value": "Declared"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 8 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nSalbutamol\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Stan po operacji VSD. Obserwacja w kierunku choroby w\u0119z\u0142a zatokowego\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z chorob\u0105 w\u0119z\u0142a zatokowego przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia krwi + PLT rozdzia\u0142 5 cz\u0119\u015b\u0107 WBC\n    WBC Krwinki bia\u0142e:8.58[10^3/ul]\n    RBC Krwinki czerwone:5.03[10^6/ul]\n    HGB Hemoglobina:13.8[g/dl]\n    HCT Hematokryt:39.1[%]\n    MCV wska\u017anik czerwonokrw:77.7[fl]\n    MCH wska\u017anik czerwonokrw:27.4[pg]\n    MCHC wska\u017anik czerwonokr:35.3[g/dl]\n    PLT z morfologii:296[10^3/ul]\n    RDW-SD:36.2[fl]\n    RDW-CV:13.0[%]\n    PDW:11.2[fl]\n    MPV:10.3[fl]\n    P-LCR:26.7[%]\n    PCT (hematokryt p\u0142ytkowy:0.30[%]\n    NEUTR# warto\u015b\u0107 bezwzgl\u0119d:3.98[10^3/ul]\n    NEUTR%:46.3[%]\n    LYMH# warto\u015b\u0107 bezwzgl\u0119dn:3.12[10^3/ul]\n    LYMPH%:36.4[%]\n    MONO# warto\u015b\u0107 bezwzgl\u0119dn:0.76[10^3/ul]\n    MONO%:8.9[%]\n    EO# warto\u015b\u0107 bezwzgl\u0119dna:0.65[10^3/ul]\n    EO%:7.6[%]\n    BASO# warto\u015b\u0107 bezwzgl\u0119dn:0.07[10^3/ul]\n    BASO%:0.8[%]\n    NRBC %:0.1[%]\n    NRBC #:0.01[10^3/ul]\nTSH: TSH:4.11[uIU/ml]\nFT3: FT3:3.87[pg/ml]\nFT4: FT4:1.24[ng/dl]\nALAT: ALAT:17[U/L]\nASPAT: ASPAT:37[U/L]\nKreatynina + GFR\n    Kreatynina w surowicy:0.53[mg/dl]\n    eGFR stand. wg Schwartza:130.8[ml/min/1,73 m^2]\n    eGFR zmod. wg Schwartza:98.2[ml/min/1,73 m^2]\n    wzrost:126[cm]\nMleczany (LAC): Mleczany:27.0[mg/dl]\nMocznik: Mocznik:31[mg/dl]\nProfil parametr\u00f3w krytycznych (ABL)\n    pH:7.352\n    pCO2:44.0[mmHg]\n    BE:-1.40[mmol/L]\n    HCO3:23.8[mmol/L]\n    pO2:51.3[mmHg]\n    O2Sat:83.7[%]\n    S\u00f3d (ABL):138[mmol/L]\n    Potas (ABL):6.7[mmol/L]\n    Chlorki (ABL):106[mmol/L]\n    Wap\u0144 zjonizowany (ABL):1.24[mmol/L]\n    Ht - ABL:43.8[%]\n    Hb - ABL:14.3[g/dl]\n    FO2Hb:82.3[%]\n    FCOHb:0.9[%]\n    FMetHb:0.8[%]\n    Glukoza (ABL):99[mg/dl]\n    Mleczany:28[mg/dl]\nNT-proBNP surowica: NT-proBNP w surowicy:194[pg/ml]\n------------------------------------------------\nICD10\n------------------------------------------------\nZ98.8\nZ03.5\nQ21.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\nC55\n89.41\nL69\nO55\nI17\nN11\nI19\nM37\nN24\nN13\n88.721\nO69\n------------------------------------------------"
}